InvestorsHub Logo
Followers 26
Posts 3952
Boards Moderated 0
Alias Born 09/02/2012

Re: Paullee post# 659

Thursday, 04/16/2020 6:38:47 AM

Thursday, April 16, 2020 6:38:47 AM

Post# of 1159
During J&J’s first quarter earnings call, Chief Scientific Officer Paul Stoffels said the company is also negotiating with partners in Europe and Asia to produce the vaccine, and partnerships will be announced in the coming weeks.

Can't wait!!

https://www.fool.com/earnings/call-transcripts/2020/04/14/johnson-johnson-jnj-q1-2020-earnings-call-transcri.aspx

As we have already announced, we are expanding our global manufacturing capacity in parallel, including the establishment of a new U.S. vaccine manufacturing capability. We are also in discussions with other potential partners to expand manufacturing capacity in Europe and Asia and look forward to making those announcements in the coming weeks. We plan to begin production at risk imminently and our goal is to enable the supply of more than 1 billion doses of the vaccine globally.

Can we all dream?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DYAI News